Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces

International Journal of Colorectal Disease

Volumn 14, Issue 6, 1999, Pages 267-271

  Sieg, Andreas ^a,b   Thoms, Christine ^b   Lüthgens, Kai ^b   John, Markus R ^b   Schmidt Gayk, Heinrich ^b  

^a Practice of Gastroenterology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colonic polyps; Colorectal cancer; Hemoglobin; Hemoglobin haptoglobin complex; Occult blood

Indexed keywords

GUAIAC; HAPTOGLOBIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CHEMOLUMINESCENCE; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL CARCINOMA; COLORECTAL TUMOR; DIAGNOSTIC PROCEDURE; FECES; FEMALE; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL;

EID: 0033380916     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840050226     Document Type: Article

References (32)

1. Frommer DJ, Kapparis A, Brown MK (1988) Improved screening for colorectal cancer by immunological detection of occult blood. BMJ 96:1092-1094
2. Allison JE, Feldman R, Tekawa IS (1990) Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value: long-term follow-up in a large group practice setting. Ann Intern Med 112:328-333
3. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Maillard JA, Gerstner JB, Pandya K, Ellefson RD (1993) Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and Hemoquant tests. JAMA 269:1262-1267
4. Allison JE, Tekawa IS, Ransom LR, Adrain AL (1996) Comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 334:155-159
5. Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K (1998) Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med 339:153-159
6. Verne JECW, Aubrey R, Love SB, Talbot IC, Northover JMA (1998) Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317:182-185
7. Macrae FA, St John DJB, Calagiore P, Taylor LS, Legge WJ (1982) Optimal dietary conditions for Hemoccult testing. Gastroenterology 82:899-903
8. Jaffe RM, Kasten B, Young DS, MacLowry JD (1975) False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 83:824-826
9. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Satya SA, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1477
10. Kronborg O, Fenger C, Olson J, Jörgensen OD, Söndergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467-1471
11. Mandel JS, Bond JH, Church TR, Snover DC, Bradley MG, Schumann LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328:1365-1371
12. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C (1998) A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 317:559-565
13. Robinson MHE, Marks CG, Farrands PA, Whynes DK, Bostok K, Hardcastle JD (1995) Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study. Eur J Surg Oncol 21:261-264
14. Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ (1996) Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut 39:722-725
15. St John DJB, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC (1993) Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104:1661-1668
16. Sieg A, Scheida M, John MR, Hertel A, Schröter M, Lüthgens K, Schmidt-Gayk H (1998) Validity of new immunological human hemoglobin and albumin tests in detecting colorectal neoplasms - an endoscopy-controlled study. Z Gastroenterol 36:485-490
17. Morrow RJ, Lawson N, Hussaini SH, Asquith P (1990) The usefulness of faecal haemoglobin, albumin and alpha-1-antitrypsin in the detection of gastrointestinal bleeding. Ann Clin Biochem 27:208-212
18. Florent C, L'Hirondel C, Desmazures C, et al (1981) Intestinal clearance of alpha-1-antitrypsin. A sensitive method for the detection of protein losing enteropathy. Gastroenterology 81:777-780
19. Meguro T (1994) Measurement of fecal hemoglobin-haptoglobin complex as a new diagnostic tool of lower gastrointestinal tract diseases. Hokkaido Igaku Zasshi 69:995-1009
20. Lüthgens K, Maier A, Kampert I, Sieg A, Schmidt-Gayk H (1998) Hemoglobin-haptoglobin complex. A highly sensitive assay for the detection of fecal occult blood. Clin Lab 44:543-551
21. Gao P, John MR, Schmidt-Gayk H, Arndt B, Scheida M, Theuer D (1995) Solid-phase competitive luminescence immunoassay for lysozyme in faeces. Clin Chim Acta 239:167-177
22. Abel U (1993) Die Bewertung diagnostischer Tests. Hippokrates, Stuttgart
23. Royall RM (1976) Current advances in sampling theory: implications for human observational studies. Am J Epidemiol 104:463-474
24. Saah AJ, Hoover DR (1997) Sensitivity and specificity reconsidered: the meaning of these terms in analytical and diagnostic settings. Ann Intern Med 126:91-94
25. Zöfel P (1992) Statistik in der Praxis. Fischer, Stuttgart
26. Winaver SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, and the National Polyp Study Workgroup (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329:1977-1981
27. Sieg A Hertel A, John MR, Lüthgens K, Schmidt-Gayk H (1998) Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test. Eur J Cancer Prev 7:279-285
28. Ransohoff DF, Lang CA (1997) Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Intern Med 126:811-822
29. Liebermann DA (1995) Cost-effectiveness model for colon cancer screening. Gastroenterology 109:1781-1790
30. Toribara NW (1995) Sleisinger MH. Screening for colorectal cancer. N Engl J Med 332:861-867
31. Winaver SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiaths TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardello FM Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594-642
32. Sieg A, Schröter M, Hertel A, Schmidt-Gayk H (1996) Die Prevention des kolorektalen Karzinoms nach dem Östringer Modell ist kosteneffektiv. Z Gastroenterol 9:610(A)